Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus

Infection Control and Hospital Epidemiology

Volumn 17, Issue 12, 1996, Pages 780-785

  Kluytmans, Jan A J W ^a,c   Mouton, Johan W ^a   Vandenbergh, Marjolein F Q ^a   Manders, Marie José A A J ^a   Maat, Alexander P W M ^a   Wagenvoort, Johan H T ^b   Michel, Marc F ^a   Verbrugh, Henri A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c Ignatius Hospital   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PSEUDOMONIC ACID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HETEROZYGOTE; HUMAN; INCIDENCE; INFECTION CONTROL; INTRANASAL DRUG ADMINISTRATION; MALE; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; NOSE MUCOSA; OINTMENT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; THORAX SURGERY;

ADMINISTRATION, INTRANASAL; ANTI-BACTERIAL AGENTS; CARRIER STATE; FEMALE; HUMANS; INCIDENCE; INFECTION CONTROL; MALE; MIDDLE AGED; MUPIROCIN; NASAL MUCOSA; OINTMENTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; THORACIC SURGERY;

EID: 0030340985     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141170     Document Type: Article

References (29)

1. Doebbeling BN, Pfaller MA, Kuhns KR, Massanari RM, Behrendt DM, Wenzel RP Cardiovascular surgery prophylaxis. A randomized, controlled comparison of cefazolin and cefuroxime. J Thorac Cardiovasc Surg 1990;99:981-989.
2. Huytmans JAJW, Mouton JW, Maat APWM, Manders MAAJ, Michel MF, Wagenvoort JHT. Surveillance of postoperative infections in thoracic surgery. J Hosp Infect 1994;27:139-147.
3. Green JW, Wenzel RP. Postoperative wound infection: a controlled study of the increased duration of hospital stay and direct cost of hospitalization. Ann Surg 1977;185:264-268.
4. Nelson RM, Dries DJ. The economic implications of infection in cardiac surgery. Ann Thorac Surg 1986;42:240-246.
5. Loop FD, Lytle BW, Cosgrove DM, et al. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 1990;49:179-187.
6. Weinstein HJ. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. N Engl J Med 1959;260:1303-1308.
7. Williams REO, Jevons PM, Shooter RA, et al. Nasal staphylococci and sepsis in hospital patients. BMJ 1959;ii:658-663.
8. Calia FM, Wolinsky E, Mortimer EA, Abrams JS, Rammelkamp CH. Importance of the carrier state as a source of Staphylococcus aureus in wound sepsis. Journal of Hygiene (Cambridge) 1969;67:49-57.
9. Muytmans JAJW, Mouton JW, Ijzerman EPF, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995;171:216-219.
10. Doebbeling BN, Breneman DL, Neu HC, the Mupirocin Collaborative Study Group. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. Clin Infect Dis 1993;17:466-474.
11. Holton DL, Nicolle LE, Diley D, Bernstein K. Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic hemodialysis patients. J Hosp Infect 1991;17:133-137.
12. Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991;114:101-106.
13. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Grace Emori T. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-608.
14. Fuchs PC, Jones RN, Barry AL Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990;28:608-609.
15. SAS institute Inc. SAS Users Guide. Gary, NC: SAS Institute Inc; 1989.
16. Chow JW, Yu VL Staphylococcus aureus nasal carriage in hemodialysis patients. Arch Intern Med 1989;149:1258-1262.
17. Goldblum SE, Reed WP, Ulrich JA, Goldman RS. Staphylococcal carriage and infections in hemodialysis patients. Dial Transplant 1978;7:1140-1148.
18. Yu VL, Goetz A, Wagener M, et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. N Engl J Med 1986;315:91-96.
19. Boelaert JR, DeSmedt RA, De Baere YA, et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in hemodialysis patients. Nephrol Dial Transplant 1989;4:278-281.
20. Kluytmans JAJW, Manders M-J, van Bommel E, Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996; 17:793-797.
21. Doebbeling BN, Breneman DL, Neu HC, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment Clin Infect Dis 1993;17:466-474.
22. Ulicny KS, Hiratzka LE The risk factors of median sternotomy infection: a current review. J Card Surg 1991;6:338-351.
23. Sethi GK, Copeland JG, Moritz T, Henderson W, Zadina K, Goldman S. Comparison of postoperative complication between saphenous vein and IMA grafts to left anterior descending coronary artery. Ann Thorac Surg 1991;51:733-738.
24. Ogtrop ML Effect of broth enrichment cultures on ability to detect carriage of Staphylococcus aureus. Antimicrob Agents Chemother 1996;39:2169. Letter.
25. Gilbart J, Perry CR, Slocombe B. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-TRNA synthetases. Antimicrob Agents Chemother 1993;37:32-38.
26. Chatfield CA, O'Neill WA, Cooke RPD, et al. Mupirocin-resistant Staphylococcus aureus in a specialist school population. J Hosp Infect 1994;26:273-278.
27. Cookson BD, Lacey RW, Noble WC, Reeves DS, Wise R, Redhead RJ. Mupirocin-resistant Staphylococcus aureus. Lancet 1990;335:1095-1096.
28. Smith GE, Kennedy CTC. Staphylococcus aureus resistant to mupirocin. J Antimicrobo Chemother 1988;21:141-142.
29. Hudson IRB. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect 1994;27:81-98.